Shibuya K, Fujisawa T, Hoshino H, Baba M, Saitoh Y, Iizasa T, Suzuki M, Otsuji M, Hiroshima K, Ohwada H
Department of Surgery, Institute of Pulmonary Cancer Research, Chiba University School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
Lung Cancer. 2001 Apr;32(1):19-25. doi: 10.1016/s0169-5002(00)00200-2.
A new strategy in the treatment of squamous cell carcinoma of the tracheobronchial tree is the detection and eradication of preinvasive bronchial lesions before they become invasive cancers. It is, however, difficult to detect preinvasive lesions by conventional white-light bronchoscopy alone.
we conducted a detailed investigation on the use of fluorescence bronchoscopy in the detection of preinvasive bronchial lesions in patients with sputum cytology suspicious or positive for malignancy.
64 participants with sputum cytology suspicious or positive for malignancy were examined with both white light and fluorescence bronchoscopy (LIFE group). Earlier to this study, before fluorescence bronchoscopy became available in our institute, 48 participants having sputum cytology suspicious or positive for malignancy were examined with white light bronchoscopy alone (control group). Biopsy specimens for pathological examinations were taken of all abnormal areas discovered by white light or fluorescence bronchoscopy examination.
In sputum cytology suspicious or positive for malignancy, the diagnosis of preinvasive bronchial lesions was greatly enhanced in the LIFE group as compared with the control group (45 vs. 7 lesions). The percentage of participants with preinvasive bronchial lesions was also significantly higher in the LIFE group than in the control group (40.6 vs. 12.5%, P = 0.00087, respectively).
Our study suggests that the use of fluorescence bronchoscopy in addition to conventional white-light examination could greatly enhance the detection and localization of preinvasive bronchial lesions in patients with sputum cytology suspicious or positive for malignancy.
气管支气管树鳞状细胞癌治疗的一种新策略是在侵袭性癌症形成之前检测并根除侵袭前支气管病变。然而,仅通过传统的白光支气管镜检查很难检测到侵袭前病变。
我们对荧光支气管镜在痰细胞学检查怀疑或确诊为恶性肿瘤的患者中检测侵袭前支气管病变的应用进行了详细研究。
64例痰细胞学检查怀疑或确诊为恶性肿瘤的参与者接受了白光和荧光支气管镜检查(LIFE组)。在本研究之前,在我们研究所可使用荧光支气管镜之前,48例痰细胞学检查怀疑或确诊为恶性肿瘤的参与者仅接受了白光支气管镜检查(对照组)。对白光或荧光支气管镜检查发现的所有异常区域采集活检标本进行病理检查。
在痰细胞学检查怀疑或确诊为恶性肿瘤的患者中,与对照组相比,LIFE组侵袭前支气管病变的诊断有了显著提高(45处病变对7处病变)。LIFE组中存在侵袭前支气管病变的参与者百分比也显著高于对照组(分别为40.6%对12.5%,P = 0.00087)。
我们的研究表明,除了传统的白光检查外,使用荧光支气管镜可以大大提高痰细胞学检查怀疑或确诊为恶性肿瘤的患者中侵袭前支气管病变的检测和定位。